Shanghai Hile Bio-Technology Co., Ltd.

¥2.98As of Sun 8 Nov 2026, 12:00 UTC
SSE:603718Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (16.44%)
Div yield —
ROE (22.14%)
Biotechnology
Beta (5Y) 0.22
PE TTM —
TSR TTM (56.69%)
Mkt cap ¥1.934B
ROIC 7.17%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥3.22
8.03%
(62.36%)
Hold 5|1|2|2|12
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.05
0.05
0.05
0.05
25.39%
18.33%
21.26%
11.42%
Revenue¥M
174.7
175.8
183.4
184.6
5.59%
3.14%
8.55%
4.77%
Peers (US$289.9M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.351
0.170
0.151
EBIT/Intx
0.954
0.042
0.040
Own earn%
183.89
(7.48)
9.25
Sh yield%
45.64
33.11
33.70
Owners
Insiders/Inst%
7.40
84.39
Short interest%
4.82
SBC / revenue%
4.97
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
0
Op margin range%
5–12
$1 testx
0.0
Incr. ROIC%
6